BSGI Posts Higher Sensitivity than Mammography or MRI for the Detection of Ductal Carcino... (nosed only after BSGI demonstrated an oc...)

BSGI Posts Higher Sensitivity than Mammography or MRI for the Detection of Ductal Carcinoma In Situ

Date:8/19/2007

nosed only after BSGI demonstrated an occult focus of radiotracer uptake in the contra lateral breast, previously undetected by mammography. There were two false negative BSGI studies.

Details about BSGI with the Dilon 6800 Gamma Camera

Breast-Specific Gamma Imaging (BSGI) performed with the Dilon 6800, is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers. BSGI serves as a complementary diagnostic adjunctive procedure to mammography and ultrasound for difficult-to-diagnose patients. With BSGI, the patient receives a radioactive tracing agent that is absorbed by all the cells in the body. Cancerous cells in the breast, due to their increased rate of metabolic activity, absorb a greater amount of the tracing agent than normal, healthy cells and generally appear as "hot spots" on the BSGI image.

BSGI is ideal for patients with mammograms that are difficult to interpret due to a variety of factors, such as: dense breast tissue, suspicious areas on a mammogram, lumps that can be felt but not seen with mammography or ultrasound, implants and breast augmentation, scarring from previous surgeries and for women with a strong positive family history of breast cancer.

About Dilon Technologies

Dilon Technologies is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; Northwestern Memorial Hospital, Chicago; and The Rose, Houston. For more information about Dilon Technologies please visit '/>"/>

SOURCE Dilon Technologies

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Data on Higher Dose of Copaxone and Data Showing Copaxone is Most Cost Effective
2. Data Published in Neurology Showed That Higher Dose of Copaxone Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
3. New Clinical Study Results Indicate Higher Early Virologic Response with Celgosivir Combination Therapy in HCV Non-Responders
4. Diabetes Linked to Higher Parkinsons Risk
5. Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
6. Digital vs. Analog Mammography
7. Fast, Accurate Influenza A/B Antigen Detection
8. GSKS Pazopanib Shows Positive Results in Patients with Advanced Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma

Post Your Comments:

BSGI Posts Higher Sensitivity than Mammography or MRI for the Detection of Ductal Carcino...(nosed only after BSGI demonstrated an oc...),Health